STTK logo

Shattuck Labs, Inc.

STTK
Healthcare|Biotechnology|US
$4.62
+0.13 (+2.90%)
DCF Value
$0.61
Tangible Book / Share
$1.06
Cash / Share
$1.07
Next Earnings Report
Mar 4, 2027
EPS est. -$0.12 · Revenue est. $88.9K
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Jun 11, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (1)

Jul 2028
Est. completion
P2Crohn's Disease
A Study of SL-325 in Crohn's Disease Patients
NCT07753850n=232

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

Jul 2026
P1
Phase 1 Study of SL-325 in Healthy Volunteers
NCT07158437

Recent Press Releases

Shattuck Labs Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Nov 5, 2026 · GlobeNewsWire
Shattuck Labs Announces Two Poster Presentations at UEG Week 2026
Oct 13, 2026 · GlobeNewsWire
Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development
Oct 1, 2026 · GlobeNewsWire
Shattuck Labs Announces Participation in Upcoming September Investor Conferences
Sep 2, 2026 · GlobeNewsWire

SEC Filings (64)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 202610-QQuarterly reportDocumentIndex
Nov 5, 20268-KMaterial eventDocumentIndex
Oct 27, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 11, 2026S-8Employee stock planDocumentIndex
Aug 11, 20268-KMaterial eventDocumentIndex
Aug 11, 202610-QQuarterly reportDocumentIndex
Jul 17, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 15, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 11, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 11, 20268-KMaterial eventDocumentIndex
Jun 11, 2026424B5Offering prospectusDocumentIndex
Jun 9, 2026424B5Offering prospectusDocumentIndex
Jun 9, 20268-KMaterial eventDocumentIndex
Jun 2, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 7, 202610-QQuarterly reportDocumentIndex
May 7, 20268-KMaterial eventDocumentIndex
Apr 8, 2026ARSAnnual report to holdersDocumentIndex
Apr 8, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 8, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 5, 202610-KAnnual reportDocumentIndex
Mar 5, 20268-KMaterial eventDocumentIndex
Feb 6, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 5, 20268-KMaterial eventDocumentIndex
Jan 22, 20268-KMaterial eventDocumentIndex
Jan 22, 2026424B5Offering prospectusDocumentIndex
Jan 21, 2026EFFECTDocumentIndex
Jan 13, 2026S-3Shelf registrationDocumentIndex
Nov 13, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 6, 20258-K/AMaterial eventDocumentIndex
Nov 6, 202510-QQuarterly reportDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Sep 30, 2025424B3Offering prospectusDocumentIndex
Sep 26, 2025EFFECTDocumentIndex
Sep 18, 2025S-3Shelf registrationDocumentIndex
Sep 2, 2025SC 13DActivist / 5%+ stakeDocumentIndex
Aug 26, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 26, 20258-KMaterial eventDocumentIndex